Teva - How Low Can You Go?

6/13/17

(Image Source: 10 Cool Musical Games)

For being a pharmaceutical company, Teva (NYSE:TEVA) has gotten me more sick as a shareholder than when I was just using its drugs. Teva has been cut way too many times for anyone to not feel it, and as someone who first initiated a position in the low 40s, then 30s, and then high 20s, at some point, you wonder how long you can play limbo without breaking your back? It's not all doom and gloom for the multi-national conglomerate, as there is light at the end of the tunnel. Whether that light leads to heaven or an early grave for this investor, time will only tell, but I have faith in this company even if the numbers wouldn't corroborate my sentiment and analysis.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.